True or False: CMS requires a PHQ-2 depression screening for all patients receiving Medicare Home Health benefits.

True or False: CMS requires a PHQ-2 depression screening for all patients receiving Medicare Home Health benefits.

• A. True
• B. False
• C. Only for patients over 65
• D. Only upon request

Answer: (B)

The statement is false. The Centers for Medicare & Medicaid Services (CMS) does not mandate a PHQ-2 depression screening for all patients receiving Medicare Home Health benefits. While depression screening is encouraged and can be a valuable part of the assessment process, it is not universally required for every patient in home health settings. Instead, the PHQ-2 screening is generally recommended as part of a comprehensive assessment when patients show signs of depression or are at risk for depressive disorders. This means that while some patients may be screened, it is not a blanket requirement across all Medicare Home Health recipients. The other options consider various specific criteria or conditions under which the screening might be required, none of which encompass the general mandate for all patients. Thus, understanding the guidelines demonstrates that a universal PHQ-2 screening is not a CMS requirement, supporting the conclusion that the statement is indeed false.

The statement is false. The Centers for Medicare & Medicaid Services (CMS) does not mandate a PHQ-2 depression screening for all patients receiving Medicare Home Health benefits. While depression screening is encouraged and can be a valuable part of the assessment process, it is not universally required for every patient in home health settings.

Instead, the PHQ-2 screening is generally recommended as part of a comprehensive assessment when patients show signs of depression or are at risk for depressive disorders. This means that while some patients may be screened, it is not a blanket requirement across all Medicare Home Health recipients.

The other options consider various specific criteria or conditions under which the screening might be required, none of which encompass the general mandate for all patients. Thus, understanding the guidelines demonstrates that a universal PHQ-2 screening is not a CMS requirement, supporting the conclusion that the statement is indeed false.